Dyne Therapeutics, Inc. (DYN)
USD 7.48
(-9.66%)
USD 7.48
(-9.66%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -235.93 Million USD | -42.79% |
| 2022 | -165.23 Million USD | -10.69% |
| 2021 | -149.28 Million USD | -154.15% |
| 2020 | -58.73 Million USD | -333.93% |
| 2019 | -13.53 Million USD | -181.36% |
| 2018 | -4.81 Million USD | -106.33% |
| 2017 | 76 Million USD | 106.13% |
| 2016 | -1.24 Billion USD | -2580.0% |
| 2015 | 50 Million USD | 174.63% |
| 2014 | -67 Million USD | 81.18% |
| 2013 | -356 Million USD | -509.2% |
| 2012 | 87 Million USD | 105.29% |
| 2011 | -1.64 Billion USD | -602.99% |
| 2010 | -234 Million USD | 81.46% |
| 2009 | -1.26 Billion USD | -825.29% |
| 2008 | 174 Million USD | -34.09% |
| 2007 | 264 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -65.64 Million USD | 1.48% |
| 2024 Q2 | -65.1 Million USD | 0.83% |
| 2023 Q3 | -60.21 Million USD | 7.23% |
| 2023 Q2 | -64.9 Million USD | -52.72% |
| 2023 FY | -235.93 Million USD | -42.79% |
| 2023 Q1 | -42.49 Million USD | -13.3% |
| 2023 Q4 | -66.63 Million USD | -10.68% |
| 2022 Q3 | -40.49 Million USD | 22.59% |
| 2022 FY | -165.23 Million USD | -10.69% |
| 2022 Q4 | -37.51 Million USD | 7.36% |
| 2022 Q1 | -35.38 Million USD | 31.67% |
| 2022 Q2 | -52.3 Million USD | -47.82% |
| 2021 Q3 | -42.58 Million USD | -42.15% |
| 2021 FY | -149.28 Million USD | -154.15% |
| 2021 Q4 | -51.78 Million USD | -21.61% |
| 2021 Q2 | -29.95 Million USD | -19.97% |
| 2021 Q1 | -24.96 Million USD | 12.85% |
| 2020 Q2 | -8.98 Million USD | -13.9% |
| 2020 Q1 | -7.88 Million USD | -45.96% |
| 2020 Q3 | -13.92 Million USD | -54.98% |
| 2020 FY | -58.73 Million USD | -333.93% |
| 2020 Q4 | -28.64 Million USD | -105.81% |
| 2019 Q3 | -5.87 Million USD | -227.62% |
| 2019 Q1 | -1.79 Million USD | 0.0% |
| 2019 FY | -13.53 Million USD | -181.36% |
| 2019 Q4 | -5.4 Million USD | 7.97% |
| 2019 Q2 | -1.79 Million USD | 0.0% |
| 2018 FY | -4.81 Million USD | -106.33% |
| 2017 FY | 76 Million USD | 106.13% |
| 2017 Q4 | -1.41 Billion USD | -960.9% |
| 2017 Q3 | -133 Million USD | 55.07% |
| 2017 Q2 | -296 Million USD | -149.58% |
| 2017 Q1 | 597 Million USD | 428.02% |
| 2016 Q1 | -10 Million USD | 92.54% |
| 2016 Q2 | -803 Million USD | -7930.0% |
| 2016 Q3 | -249 Million USD | 68.99% |
| 2016 Q4 | -182 Million USD | 26.91% |
| 2016 FY | -1.24 Billion USD | -2580.0% |
| 2015 FY | 50 Million USD | 174.63% |
| 2015 Q4 | -134 Million USD | -458.33% |
| 2015 Q3 | -24 Million USD | -106.19% |
| 2015 Q2 | 388 Million USD | 315.56% |
| 2015 Q1 | -180 Million USD | -276.47% |
| 2014 Q1 | -37 Million USD | 59.34% |
| 2014 Q4 | 102 Million USD | 2140.0% |
| 2014 Q3 | -5 Million USD | 95.9% |
| 2014 Q2 | -122 Million USD | -229.73% |
| 2014 FY | -67 Million USD | 81.18% |
| 2013 Q3 | 22 Million USD | 115.17% |
| 2013 Q4 | -91 Million USD | -513.64% |
| 2013 FY | -356 Million USD | -509.2% |
| 2013 Q1 | -142 Million USD | -111.1% |
| 2013 Q2 | -145 Million USD | -2.11% |
| 2012 Q4 | 1.27 Billion USD | 1927.14% |
| 2012 Q3 | -70 Million USD | 93.42% |
| 2012 FY | 87 Million USD | 105.29% |
| 2012 Q2 | -1.06 Billion USD | -1734.48% |
| 2012 Q1 | -58 Million USD | 95.79% |
| 2011 Q3 | -75 Million USD | 35.34% |
| 2011 Q1 | -77 Million USD | 53.05% |
| 2011 Q2 | -116 Million USD | -50.65% |
| 2011 Q4 | -1.37 Billion USD | -1736.0% |
| 2011 FY | -1.64 Billion USD | -602.99% |
| 2010 Q1 | 145 Million USD | 140.73% |
| 2010 Q4 | -164 Million USD | -583.33% |
| 2010 FY | -234 Million USD | 81.46% |
| 2010 Q3 | -24 Million USD | 87.43% |
| 2010 Q2 | -191 Million USD | -231.72% |
| 2009 Q1 | - USD | 100.0% |
| 2009 Q4 | -356 Million USD | -59.64% |
| 2009 FY | -1.26 Billion USD | -825.29% |
| 2009 Q3 | -223 Million USD | 67.35% |
| 2009 Q2 | -683 Million USD | 0.0% |
| 2008 Q4 | -7 Million USD | -101.16% |
| 2008 FY | 174 Million USD | -34.09% |
| 2008 Q1 | -152 Million USD | -230.43% |
| 2008 Q2 | -272 Million USD | -78.95% |
| 2008 Q3 | 605 Million USD | 322.43% |
| 2007 Q3 | 220 Million USD | 189.47% |
| 2007 FY | 264 Million USD | 0.0% |
| 2007 Q4 | -46 Million USD | -120.91% |
| 2007 Q2 | 76 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| AbCellera Biologics Inc. | -146.39 Million USD | -61.161% |
| Alkermes plc | 355.75 Million USD | 166.32% |
| Agenus Inc. | -245.76 Million USD | 3.997% |
| Aptorum Group Limited | -2.82 Million USD | -8252.796% |
| Ardelyx, Inc. | -66.06 Million USD | -257.118% |
| Dyadic International, Inc. | -6.79 Million USD | -3371.979% |
| Eton Pharmaceuticals, Inc. | -936 Thousand USD | -25106.944% |
| Lantern Pharma Inc. | -15.96 Million USD | -1378.16% |
| Inhibikase Therapeutics, Inc. | -19.02 Million USD | -1139.889% |
| Novavax, Inc. | -545.06 Million USD | 56.714% |
| Janux Therapeutics, Inc. | -58.29 Million USD | -304.743% |
| Pyxis Oncology, Inc. | -73.79 Million USD | -219.741% |
| TransCode Therapeutics, Inc. | -18.54 Million USD | -1172.165% |
| Ocuphire Pharma, Inc. | -9.98 Million USD | -2262.678% |
| Outlook Therapeutics, Inc. | -58.98 Million USD | -300.011% |
| Madrigal Pharmaceuticals, Inc. | -373.63 Million USD | 36.853% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.33 Million USD | -869.367% |
| SELLAS Life Sciences Group, Inc. | -37.34 Million USD | -531.861% |
| Syros Pharmaceuticals, Inc. | -164.57 Million USD | -43.362% |
| Barinthus Biotherapeutics plc | -73.34 Million USD | -221.672% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | -1062.767% |
| Xeris Biopharma Holdings, Inc. | -62.25 Million USD | -278.985% |
| Clearside Biomedical, Inc. | -32.48 Million USD | -626.295% |
| C4 Therapeutics, Inc. | -132.49 Million USD | -78.075% |
| Alnylam Pharmaceuticals, Inc. | -440.24 Million USD | 46.407% |
| AlloVir, Inc. | -190.41 Million USD | -23.905% |
| Arrowhead Pharmaceuticals, Inc. | -205.27 Million USD | -14.937% |
| VYNE Therapeutics Inc. | -28.45 Million USD | -729.246% |
| Bicycle Therapeutics plc | -180.66 Million USD | -30.594% |
| BioXcel Therapeutics, Inc. | -179.05 Million USD | -31.769% |
| ChromaDex Corporation | -4.93 Million USD | -4677.987% |
| Chimerix, Inc. | -82.09 Million USD | -187.395% |
| Corbus Pharmaceuticals Holdings, Inc. | -44.6 Million USD | -428.967% |
| Caribou Biosciences, Inc. | -102.07 Million USD | -131.152% |
| CRISPR Therapeutics AG | -153.61 Million USD | -53.595% |
| Precision BioSciences, Inc. | -61.31 Million USD | -284.77% |
| Fate Therapeutics, Inc. | -160.92 Million USD | -46.61% |
| Fortress Biotech, Inc. | -60.63 Million USD | -289.097% |
| Fortress Biotech, Inc. | -60.63 Million USD | -289.097% |
| HOOKIPA Pharma Inc. | -81.58 Million USD | -189.209% |
| ImmuCell Corporation | -5.77 Million USD | -3985.774% |
| IDEAYA Biosciences, Inc. | -112.96 Million USD | -108.866% |
| Immix Biopharma, Inc. | -15.42 Million USD | -1429.471% |
| Incyte Corporation | 597.59 Million USD | 139.481% |
| Innoviva, Inc. | 179.72 Million USD | 231.279% |
| IO Biotech, Inc. | -86.08 Million USD | -174.081% |
| Jaguar Health, Inc. | -41.3 Million USD | -471.276% |
| Keros Therapeutics, Inc. | -152.99 Million USD | -54.215% |
| Ligand Pharmaceuticals Incorporated | 52.15 Million USD | 552.385% |
| ContextLogic Inc. | -317 Million USD | 25.572% |
| MiMedx Group, Inc. | 67.43 Million USD | 449.852% |
| MEI Pharma, Inc. | 17.77 Million USD | 1427.129% |
| NextCure, Inc. | -62.72 Million USD | -276.157% |
| Onconetix, Inc. | -37.4 Million USD | -530.684% |
| Oncternal Therapeutics, Inc. | -39.47 Million USD | -497.627% |
| Opthea Limited | -220.24 Million USD | -7.126% |
| Psyence Biomedical Ltd. | -51.15 Million USD | -361.183% |
| Vaxcyte, Inc. | -402.26 Million USD | 41.348% |
| PDS Biotechnology Corporation | -42.94 Million USD | -449.429% |
| Precigen, Inc. | -95.9 Million USD | -146.014% |
| Pharming Group N.V. | -10.54 Million USD | -2136.794% |
| Phathom Pharmaceuticals, Inc. | -201.59 Million USD | -17.037% |
| Pieris Pharmaceuticals, Inc. | -24.54 Million USD | -861.321% |
| PureTech Health plc | -65.69 Million USD | -259.129% |
| Rigel Pharmaceuticals, Inc. | -25.09 Million USD | -840.325% |
| Avidity Biosciences, Inc. | -212.22 Million USD | -11.176% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.33 Million USD | -869.367% |
| Sangamo Therapeutics, Inc. | -257.83 Million USD | 8.492% |
| Sol-Gel Technologies Ltd. | -27.23 Million USD | -766.205% |
| Acelyrin, Inc. | -381.64 Million USD | 38.178% |
| Salarius Pharmaceuticals, Inc. | -12.54 Thousand USD | -1880971.764% |
| Summit Therapeutics Inc. | -614.92 Million USD | 61.632% |
| Sensei Biotherapeutics, Inc. | -34.1 Million USD | -591.877% |
| Senti Biosciences, Inc. | -92.91 Million USD | -153.917% |
| Stoke Therapeutics, Inc. | -104.69 Million USD | -125.348% |
| Elevation Oncology, Inc. | -45.7 Million USD | -416.228% |
| Alaunos Therapeutics, Inc. | -35.14 Million USD | -571.42% |
| Telomir Pharmaceuticals, Inc. Common Stock | -13.07 Million USD | -1704.922% |
| Entrada Therapeutics, Inc. | -6.68 Million USD | -3429.349% |
| VistaGen Therapeutics, Inc. | -29.36 Million USD | -703.545% |
| Kintara Therapeutics, Inc. | -8.5 Million USD | -2675.403% |
| Wave Life Sciences Ltd. | -57.51 Million USD | -310.232% |
| Seer, Inc. | -86.27 Million USD | -173.465% |
| Verrica Pharmaceuticals Inc. | -66.99 Million USD | -252.171% |
| Aadi Bioscience, Inc. | -65.76 Million USD | -258.758% |
| ESSA Pharma Inc. | -26.58 Million USD | -787.57% |
| GlycoMimetics, Inc. | -36.89 Million USD | -539.406% |
| GT Biopharma, Inc. | -7.59 Million USD | -3005.66% |
| Inhibrx Biosciences, Inc. | -241.36 Million USD | 2.247% |
| Akebia Therapeutics, Inc. | -51.92 Million USD | -354.38% |
| Catalyst Pharmaceuticals, Inc. | 71.41 Million USD | 430.398% |
| Longboard Pharmaceuticals, Inc. | -54.42 Million USD | -333.532% |
| Orchestra BioMed Holdings, Inc. | -49.12 Million USD | -380.328% |
| Alzamend Neuro, Inc. | -9.94 Million USD | -2271.763% |
| Sorrento Therapeutics, Inc. | -572.84 Million USD | 58.813% |
| TRACON Pharmaceuticals, Inc. | -3.58 Million USD | -6475.725% |
| Viracta Therapeutics, Inc. | -51.05 Million USD | -362.096% |
| Rocket Pharmaceuticals, Inc. | -245.59 Million USD | 3.932% |
| Aptose Biosciences Inc. | -51.2 Million USD | -360.751% |
| ZyVersa Therapeutics, Inc. | -98.29 Million USD | -140.022% |
| Soligenix, Inc. | -6.14 Million USD | -3742.165% |
| Century Therapeutics, Inc. | -136.67 Million USD | -72.629% |
| Kura Oncology, Inc. | -152.63 Million USD | -54.58% |
| TScan Therapeutics, Inc. | -89.21 Million USD | -164.45% |
| Intensity Therapeutics, Inc. | -10.53 Million USD | -2138.916% |
| Ocean Biomedical, Inc. | 565.47 Thousand USD | 41824.053% |
| CytomX Therapeutics, Inc. | -569 Thousand USD | -41365.202% |
| Autolus Therapeutics plc | -208.38 Million USD | -13.223% |
| Mineralys Therapeutics, Inc. | -71.89 Million USD | -228.155% |
| EyePoint Pharmaceuticals, Inc. | -70.79 Million USD | -233.268% |
| Eterna Therapeutics Inc. | -21.66 Million USD | -988.873% |
| Adaptive Biotechnologies Corporation | -225.25 Million USD | -4.745% |
| GRI Bio, Inc. | -13.03 Million USD | -1709.749% |
| Xenetic Biosciences, Inc. | -4.13 Million USD | -5606.435% |
| Tenaya Therapeutics, Inc. | -124.08 Million USD | -90.143% |
| IGM Biosciences, Inc. | -246.41 Million USD | 4.253% |
| INmune Bio, Inc. | -30 Million USD | -686.247% |
| Heron Therapeutics, Inc. | -110.55 Million USD | -113.404% |
| SAB Biotherapeutics, Inc. | -42.19 Million USD | -459.175% |
| Pasithea Therapeutics Corp. | -15.96 Million USD | -1378.148% |
| Entero Therapeutics, Inc. | -15.79 Million USD | -1393.746% |
| Milestone Pharmaceuticals Inc. | -59.68 Million USD | -295.304% |
| X4 Pharmaceuticals, Inc. | -101.16 Million USD | -133.215% |
| Atara Biotherapeutics, Inc. | -276.12 Million USD | 14.555% |
| Coherus BioSciences, Inc. | -237.89 Million USD | 0.822% |
| Verastem, Inc. | -87.36 Million USD | -170.053% |
| Abeona Therapeutics Inc. | -54.18 Million USD | -335.405% |
| Pliant Therapeutics, Inc. | -161.33 Million USD | -46.24% |
| Tonix Pharmaceuticals Holding Corp. | -116.65 Million USD | -102.247% |
| Histogen Inc. | -10.62 Million USD | -2121.42% |
| Aprea Therapeutics, Inc. | -14.28 Million USD | -1551.439% |
| Surrozen, Inc. | -43.04 Million USD | -448.155% |
| Organovo Holdings, Inc. | -14.67 Million USD | -1508.186% |
| Lixte Biotechnology Holdings, Inc. | -5.08 Million USD | -4538.012% |
| Ovid Therapeutics Inc. | -52.33 Million USD | -350.787% |
| Panbela Therapeutics, Inc. | -25.26 Million USD | -833.923% |
| CASI Pharmaceuticals, Inc. | -26.93 Million USD | -775.852% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.35 Million USD | -2723.197% |
| Centessa Pharmaceuticals plc | -151.08 Million USD | -56.162% |
| Hepion Pharmaceuticals, Inc. | -48.92 Million USD | -382.232% |
| Arcturus Therapeutics Holdings Inc. | -29.72 Million USD | -693.733% |
| BioRestorative Therapies, Inc. | -10.41 Million USD | -2164.77% |
| Apollomics, Inc. | -172.6 Million USD | -36.695% |
| Amarin Corporation plc | -59.11 Million USD | -299.136% |
| Mesoblast Limited | -87.95 Million USD | -168.244% |
| Turnstone Biologics Corp. | -55.2 Million USD | -327.422% |
| Kymera Therapeutics, Inc. | -146.96 Million USD | -60.543% |
| Synaptogenix, Inc. | -6.03 Million USD | -3807.209% |
| Tiziana Life Sciences Ltd | -16.2 Million USD | -1355.682% |
| Aurinia Pharmaceuticals Inc. | -78.02 Million USD | -202.406% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -4824.109% |
| Monopar Therapeutics Inc. | -8.4 Million USD | -2708.04% |
| Exelixis, Inc. | 207.76 Million USD | 213.56% |
| Better Therapeutics, Inc. | -39.76 Million USD | -493.403% |
| Nurix Therapeutics, Inc. | -143.94 Million USD | -63.904% |
| Apellis Pharmaceuticals, Inc. | -528.62 Million USD | 55.368% |
| NLS Pharmaceutics AG | -12.17 Million USD | -1838.354% |
| Dermata Therapeutics, Inc. | -7.79 Million USD | -2926.894% |
| Aridis Pharmaceuticals, Inc. | -30.74 Million USD | -667.3% |
| Gritstone bio, Inc. | -138.49 Million USD | -70.364% |
| Jasper Therapeutics, Inc. | -64.46 Million USD | -265.992% |
| TNF Pharmaceuticals, Inc. | -3.99 Million USD | -5798.499% |
| Avid Bioservices, Inc. | -140.75 Million USD | -67.625% |
| Insmed Incorporated | -749.56 Million USD | 68.524% |
| Virpax Pharmaceuticals, Inc. | -15.18 Million USD | -1453.289% |
| MediWound Ltd. | -6.71 Million USD | -3413.058% |
| OmniAb, Inc. | -50.61 Million USD | -366.104% |
| Alector, Inc. | -130.39 Million USD | -80.946% |
| Seres Therapeutics, Inc. | -113.72 Million USD | -107.465% |
| Checkpoint Therapeutics, Inc. | -51.84 Million USD | -355.064% |
| Zai Lab Limited | -334.62 Million USD | 29.491% |
| Revance Therapeutics, Inc. | -323.98 Million USD | 27.177% |
| Aura Biosciences, Inc. | -76.4 Million USD | -208.786% |
| Lyell Immunopharma, Inc. | -234.63 Million USD | -0.556% |
| Immunic, Inc. | -93.61 Million USD | -152.037% |
| Tarsus Pharmaceuticals, Inc. | -135.89 Million USD | -73.62% |
| Veracyte, Inc. | -74.4 Million USD | -217.103% |
| InMed Pharmaceuticals Inc. | -7.67 Million USD | -2973.877% |
| FibroGen, Inc. | -284.23 Million USD | 16.991% |
| SeaStar Medical Holding Corporation | -26.23 Million USD | -799.424% |
| Adial Pharmaceuticals, Inc. | -7 Million USD | -3269.619% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.83 Million USD | -1152.805% |
| Jazz Pharmaceuticals plc | 414.83 Million USD | 156.875% |
| Cyclacel Pharmaceuticals, Inc. | -22.55 Million USD | -946.052% |
| Amylyx Pharmaceuticals, Inc. | 49.27 Million USD | 578.856% |
| TG Therapeutics, Inc. | 12.67 Million USD | 1961.877% |
| Galecto, Inc. | -38.34 Million USD | -515.236% |
| Calithera Biosciences, Inc. | -18.86 Million USD | -1150.594% |
| Fortrea Holdings Inc. | -3.4 Million USD | -6839.324% |
| KalVista Pharmaceuticals, Inc. | -126.64 Million USD | -86.299% |
| Aptevo Therapeutics Inc. | -17.41 Million USD | -1255.103% |
| XBiotech Inc. | -24.55 Million USD | -860.773% |
| Jasper Therapeutics, Inc. | -64.46 Million USD | -265.992% |
| Lyra Therapeutics, Inc. | -62.68 Million USD | -276.415% |
| Foghorn Therapeutics Inc. | -98.42 Million USD | -139.71% |
| Y-mAbs Therapeutics, Inc. | -21.42 Million USD | -1001.12% |
| Theravance Biopharma, Inc. | -55.19 Million USD | -327.476% |
| Ultragenyx Pharmaceutical Inc. | -606.63 Million USD | 61.108% |
| Metagenomi, Inc. Common Stock | -68.25 Million USD | -245.67% |
| Vaxxinity, Inc. | -56.93 Thousand USD | -414304.398% |
| BioCryst Pharmaceuticals, Inc. | -226.53 Million USD | -4.149% |
| Gain Therapeutics, Inc. | -22.26 Million USD | -959.557% |
| Cartesian Therapeutics, Inc. | -219.71 Million USD | -7.386% |
| NexImmune, Inc. | -32.34 Million USD | -629.453% |
| Creative Medical Technology Holdings, Inc. | -5.28 Million USD | -4362.947% |
| Marker Therapeutics, Inc. | -14.04 Million USD | -1579.758% |
| Regeneron Pharmaceuticals, Inc. | 3.95 Billion USD | 105.968% |
| Chemomab Therapeutics Ltd. | -24.22 Million USD | -874.101% |
| Scopus BioPharma Inc. | -11.6 Million USD | -1932.218% |
| RAPT Therapeutics, Inc. | -116.79 Million USD | -102.004% |
| Ainos, Inc. | -13.77 Million USD | -1613.345% |
| Pluri Inc. | -20.88 Million USD | -1029.534% |
| Prothena Corporation plc | -147.02 Million USD | -60.471% |
| Adaptimmune Therapeutics plc | -113.87 Million USD | -107.197% |
| Celularity Inc. | -196.29 Million USD | -20.195% |
| Rallybio Corporation | -74.56 Million USD | -216.422% |
| Cue Biopharma, Inc. | -50.73 Million USD | -365.056% |
| MeiraGTx Holdings plc | -84.02 Million USD | -180.787% |
| Omeros Corporation | -117.81 Million USD | -100.264% |
| Humacyte, Inc. | -110.77 Million USD | -112.986% |
| Immunocore Holdings plc | -55.28 Million USD | -326.75% |
| Cocrystal Pharma, Inc. | -17.98 Million USD | -1211.927% |
| Cidara Therapeutics, Inc. | -22.93 Million USD | -928.9% |
| Blueprint Medicines Corporation | -506.98 Million USD | 53.463% |
| CalciMedica, Inc. | -34.35 Million USD | -586.722% |
| Cabaletta Bio, Inc. | -67.67 Million USD | -248.632% |
| Marinus Pharmaceuticals, Inc. | -141.4 Million USD | -66.852% |
| Scholar Rock Holding Corporation | -165.78 Million USD | -42.312% |
| Sana Biotechnology, Inc. | -283.25 Million USD | 16.705% |
| Pulmatrix, Inc. | -14.12 Million USD | -1570.824% |
| Elicio Therapeutics, Inc. | -35.19 Million USD | -570.371% |
| Vigil Neuroscience, Inc. | -82.63 Million USD | -185.507% |
| Intellia Therapeutics, Inc. | -481.19 Million USD | 50.968% |
| Adlai Nortye Ltd. American Depositary Shares | -104.87 Million USD | -124.978% |
| Cytokinetics, Incorporated | -526.24 Million USD | 55.166% |
| Eloxx Pharmaceuticals, Inc. | -36.06 Million USD | -554.199% |
| Nutriband Inc. | -5.48 Million USD | -4201.249% |
| Protara Therapeutics, Inc. | -40.42 Million USD | -483.714% |
| Vor Biopharma Inc. | -117.86 Million USD | -100.179% |
| Roivant Sciences Ltd. | 4.34 Billion USD | 105.425% |
| Evogene Ltd. | -23.87 Million USD | -888.052% |
| ProKidney Corp. | -35.46 Million USD | -565.211% |
| Applied Therapeutics, Inc. | -119.76 Million USD | -97.003% |
| Hoth Therapeutics, Inc. | -7.84 Million USD | -2907.333% |
| BridgeBio Pharma, Inc. | -643.2 Million USD | 63.318% |
| CorMedix Inc. | -46.33 Million USD | -409.152% |
| BioLineRx Ltd. | -60.61 Million USD | -289.245% |
| Tango Therapeutics, Inc. | -101.74 Million USD | -131.893% |
| Galectin Therapeutics Inc. | -41.06 Million USD | -474.531% |
| Atai Life Sciences N.V. | -40.22 Million USD | -486.558% |
| Renovaro Biosciences Inc. | -80.65 Million USD | -192.544% |
| Aerovate Therapeutics, Inc. | -75.52 Million USD | -212.412% |
| Zentalis Pharmaceuticals, Inc. | -292.19 Million USD | 19.252% |
| Sagimet Biosciences Inc. | -27.87 Million USD | -746.38% |
| MediciNova, Inc. | -8.57 Million USD | -2652.57% |
| Praxis Precision Medicines, Inc. | -123.27 Million USD | -91.388% |
| Cardio Diagnostics Holdings, Inc. | -8.37 Million USD | -2716.541% |
| GeoVax Labs, Inc. | -25.96 Million USD | -808.612% |
| Axsome Therapeutics, Inc. | -239.23 Million USD | 1.38% |
| Biomea Fusion, Inc. | -117.25 Million USD | -101.217% |
| PTC Therapeutics, Inc. | -626.6 Million USD | 62.347% |
| Mereo BioPharma Group plc | -29.46 Million USD | -700.709% |
| Cullinan Oncology, Inc. | -153.16 Million USD | -54.044% |
| Syndax Pharmaceuticals, Inc. | -209.36 Million USD | -12.694% |
| Absci Corporation | -110.56 Million USD | -113.39% |
| NRx Pharmaceuticals, Inc. | -30.15 Million USD | -682.544% |
| 4D Molecular Therapeutics, Inc. | -100.83 Million USD | -133.979% |
| Kiniksa Pharmaceuticals, Ltd. | 14.08 Million USD | 1775.213% |
| Ventyx Biosciences, Inc. | -192.96 Million USD | -22.271% |
| Allakos Inc. | -185.7 Million USD | -27.052% |
| Imunon, Inc. | -19.51 Million USD | -1109.005% |
| Fulcrum Therapeutics, Inc. | -97.33 Million USD | -142.397% |
| Corcept Therapeutics Incorporated | 106.14 Million USD | 322.288% |
| BioAtla, Inc. | -123.46 Million USD | -91.101% |
| NLS Pharmaceutics AG | -12.17 Million USD | -1838.354% |
| Bio-Path Holdings, Inc. | -16.07 Million USD | -1367.452% |
| Allogene Therapeutics, Inc. | -327.26 Million USD | 27.906% |
| Larimar Therapeutics, Inc. | -36.94 Million USD | -538.548% |
| XOMA Corporation | -40.83 Million USD | -477.838% |
| Kezar Life Sciences, Inc. | -101.87 Million USD | -131.606% |
| Cara Therapeutics, Inc. | -118.51 Million USD | -99.081% |
| aTyr Pharma, Inc. | -50.38 Million USD | -368.231% |
| Aligos Therapeutics, Inc. | -87.67 Million USD | -169.092% |
| Akero Therapeutics, Inc. | -151.75 Million USD | -55.468% |
| Viridian Therapeutics, Inc. | -237.73 Million USD | 0.756% |
| Eliem Therapeutics, Inc. | -35.11 Million USD | -571.822% |
| EyeGate Pharmaceuticals, Inc. | -8.09 Million USD | -2815.704% |
| Akari Therapeutics, Plc | -10 Million USD | -2257.484% |
| Tevogen Bio Holdings Inc. | -67.32 Thousand USD | -350344.857% |
| Halozyme Therapeutics, Inc. | 281.59 Million USD | 183.786% |
| Lexaria Bioscience Corp. | -6.66 Million USD | -3439.994% |
| UroGen Pharma Ltd. | -102.24 Million USD | -130.759% |
| Sutro Biopharma, Inc. | -106.79 Million USD | -120.929% |
| ZIVO Bioscience, Inc. | -7.77 Million USD | -2933.707% |
| Orgenesis Inc. | -55.36 Million USD | -326.179% |
| Entera Bio Ltd. | -8.88 Million USD | -2554.258% |
| GH Research PLC | -35.58 Million USD | -562.986% |
| Lisata Therapeutics, Inc. | -20.84 Million USD | -1032.135% |
| Reneo Pharmaceuticals, Inc. | -77.38 Million USD | -204.875% |
| Xencor, Inc. | -126.08 Million USD | -87.122% |
| 60 Degrees Pharmaceuticals, Inc. | -3.76 Million USD | -6165.419% |
| Replimune Group, Inc. | -215.79 Million USD | -9.334% |
| Coeptis Therapeutics Holdings, Inc. | -21.26 Million USD | -1009.428% |
| Vanda Pharmaceuticals Inc. | 2.5 Million USD | 9503.627% |
| Lexaria Bioscience Corp. | -6.66 Million USD | -3439.994% |
| Portage Biotech Inc. | -75.33 Million USD | -213.167% |
| Cardio Diagnostics Holdings, Inc. | -8.37 Million USD | -2716.541% |
| Olema Pharmaceuticals, Inc. | -96.65 Million USD | -144.102% |
| OncoCyte Corporation | -27.78 Million USD | -749.275% |
| Qualigen Therapeutics, Inc. | -13.41 Million USD | -1658.465% |
| Processa Pharmaceuticals, Inc. | -11.12 Million USD | -2021.446% |
| Purple Biotech Ltd. | -19.88 Million USD | -1086.806% |
| CollPlant Biotechnologies Ltd. | -7.01 Million USD | -3261.405% |
| scPharmaceuticals Inc. | -54.81 Million USD | -330.463% |
| ProMIS Neurosciences, Inc. | -17.5 Million USD | -1247.738% |
| HilleVax, Inc. | -123.56 Million USD | -90.94% |
| NeuroSense Therapeutics Ltd. | -10.1 Million USD | -2234.392% |
| Tharimmune, Inc. | -9.31 Million USD | -2431.759% |
| Genprex, Inc. | -30.86 Million USD | -664.528% |
| Neumora Therapeutics, Inc. Common Stock | -235.92 Million USD | -0.005% |
| Atossa Therapeutics, Inc. | -30.09 Million USD | -684.0% |
| XTL Biopharmaceuticals Ltd. | -1.78 Million USD | -13140.011% |
| Virios Therapeutics, Inc. | -5.29 Million USD | -4354.991% |
| OKYO Pharma Limited | -16.82 Thousand USD | -1402161.81% |
| Savara Inc. | -54.69 Million USD | -331.345% |
| Curis, Inc. | -47.41 Million USD | -397.621% |
| Daré Bioscience, Inc. | -30.16 Million USD | -682.248% |
| Carmell Therapeutics Corporation | -15.44 Million USD | -1427.586% |
| Titan Pharmaceuticals, Inc. | -5.56 Million USD | -4136.613% |
| Achieve Life Sciences, Inc. | -29.81 Million USD | -691.337% |
| BeiGene, Ltd. | -881.7 Million USD | 73.241% |
| Kiromic BioPharma, Inc. | -21.29 Million USD | -1007.998% |
| Revolution Medicines, Inc. Warrant | -436.36 Million USD | 45.932% |
| Protagonist Therapeutics, Inc. | -78.95 Million USD | -198.825% |
| Erasca, Inc. | -125.04 Million USD | -88.686% |
| bluebird bio, Inc. | -211.91 Million USD | -11.337% |
| Protagenic Therapeutics, Inc. | -5 Million USD | -4618.271% |
| BioMarin Pharmaceutical Inc. | 167.64 Million USD | 240.736% |
| DBV Technologies S.A. | -72.72 Million USD | -224.419% |
| Protagenic Therapeutics, Inc. | -5 Million USD | -4618.271% |
| Moderna, Inc. | -4.71 Billion USD | 94.995% |
| Vincerx Pharma, Inc. | -40.15 Million USD | -487.536% |
| Fresh Tracks Therapeutics, Inc. | -5.69 Million USD | -4043.607% |
| Molecular Templates, Inc. | -8.12 Million USD | -2804.197% |
| Acrivon Therapeutics, Inc. Common Stock | -60.38 Million USD | -290.702% |
| Travere Therapeutics, Inc. | -111.39 Million USD | -111.795% |
| Monte Rosa Therapeutics, Inc. | -135.35 Million USD | -74.314% |
| Spruce Biosciences, Inc. | -47.91 Million USD | -392.366% |
| Celldex Therapeutics, Inc. | -141.42 Million USD | -66.824% |
| Cogent Biosciences, Inc. | -192.41 Million USD | -22.622% |
| MacroGenics, Inc. | -9.05 Million USD | -2504.736% |
| RenovoRx, Inc. | -10.23 Million USD | -2205.874% |
| Adicet Bio, Inc. | -142.65 Million USD | -65.386% |
| Prime Medicine, Inc. | -198.13 Million USD | -19.08% |
| Aditxt, Inc. | -32.38 Million USD | -628.632% |
| Adagene Inc. | -18.94 Million USD | -1145.289% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -3126.832% |
| Quantum-Si incorporated | -95.96 Million USD | -145.87% |
| Maravai LifeSciences Holdings, Inc. | -119.02 Million USD | -98.218% |
| Acurx Pharmaceuticals, Inc. | -14.57 Million USD | -1518.471% |
| Voyager Therapeutics, Inc. | 132.33 Million USD | 278.294% |
| SciSparc Ltd. | -5.12 Million USD | -4506.345% |
| Vericel Corporation | -3.18 Million USD | -7314.739% |
| Revelation Biosciences, Inc. | -120.25 Thousand USD | -196098.879% |
| Minerva Neurosciences, Inc. | -30 Million USD | -686.316% |
| Generation Bio Co. | -126.61 Million USD | -86.346% |
| Astria Therapeutics, Inc. | -72.89 Million USD | -223.685% |
| Black Diamond Therapeutics, Inc. | -82.44 Million USD | -186.185% |
| Arcutis Biotherapeutics, Inc. | -262.14 Million USD | 9.996% |
| Invivyd, Inc. | -198.64 Million USD | -18.774% |
| Relay Therapeutics, Inc. | -341.97 Million USD | 31.007% |
| Quoin Pharmaceuticals, Ltd. | -8.68 Million USD | -2616.111% |
| Spero Therapeutics, Inc. | 22.8 Million USD | 1134.539% |
| Artelo Biosciences, Inc. | -9.87 Million USD | -2289.477% |
| 2seventy bio, Inc. | -217.57 Million USD | -8.442% |
| ADMA Biologics, Inc. | -28.23 Million USD | -735.501% |
| Clene Inc. | -49.5 Million USD | -376.602% |
| Capricor Therapeutics, Inc. | -22.28 Million USD | -958.605% |
| Boundless Bio, Inc. Common Stock | -49.43 Million USD | -377.277% |
| GeoVax Labs, Inc. | -25.96 Million USD | -808.612% |
| Recursion Pharmaceuticals, Inc. | -328.06 Million USD | 28.082% |
| Citius Pharmaceuticals, Inc. | -32.54 Million USD | -625.003% |
| Contineum Therapeutics, Inc. Class A Common Stock | 22.72 Million USD | 1138.455% |
| Relmada Therapeutics, Inc. | -98.79 Million USD | -138.823% |
| Finch Therapeutics Group, Inc. | -74.75 Million USD | -215.618% |
| ALX Oncology Holdings Inc. | -160.8 Million USD | -46.722% |
| Vir Biotechnology, Inc. | -615.06 Million USD | 61.64% |
| Evaxion Biotech A/S | -22.12 Million USD | -966.382% |
| Ocular Therapeutix, Inc. | -80.73 Million USD | -192.233% |
| Verve Therapeutics, Inc. | -200.06 Million USD | -17.928% |
| Trevena, Inc. | -40.28 Million USD | -485.611% |
| Surrozen, Inc. | -43.04 Million USD | -448.155% |
| Tyra Biosciences, Inc. | -69.13 Million USD | -241.275% |
| Cingulate Inc. | -23.53 Million USD | -902.496% |
| Galmed Pharmaceuticals Ltd. | -6.91 Million USD | -3313.44% |
| Unity Biotechnology, Inc. | -39.86 Million USD | -491.914% |
| Tenax Therapeutics, Inc. | -7.71 Million USD | -2959.876% |
| Terns Pharmaceuticals, Inc. | -90.21 Million USD | -161.542% |
| ACADIA Pharmaceuticals Inc. | -61.28 Million USD | -284.977% |
| Connect Biopharma Holdings Limited | -59.5 Million USD | -296.513% |
| Clearmind Medicine Inc. | -11.95 Million USD | -1873.537% |
| Kronos Bio, Inc. | -112.67 Million USD | -109.4% |
| Bolt Biotherapeutics, Inc. | -69.19 Million USD | -240.964% |
| CERo Therapeutics Holdings, Inc. | -2536.23 USD | -9302565.768% |
| Viking Therapeutics, Inc. | -85.89 Million USD | -174.681% |
| Statera Biopharma, Inc. | -174.4 Million USD | -35.279% |
| ImmunityBio, Inc. | -583.19 Million USD | 59.544% |
| Korro Bio, Inc. | -81.17 Million USD | -190.663% |
| Kineta, Inc. | -14.09 Million USD | -1573.431% |
| BioVie Inc. | -32.12 Million USD | -634.536% |
| Codexis, Inc. | -76.24 Million USD | -209.466% |
| Celularity Inc. | -196.29 Million USD | -20.195% |
| Crinetics Pharmaceuticals, Inc. | -214.52 Million USD | -9.979% |
| Celcuity Inc. | -63.77 Million USD | -269.928% |
| Virax Biolabs Group Limited | -6.73 Million USD | -3403.909% |
| Cibus, Inc. | -267.62 Million USD | 11.841% |
| Eledon Pharmaceuticals, Inc. | -40.32 Million USD | -485.074% |
| eFFECTOR Therapeutics, Inc. | -35.81 Million USD | -558.839% |
| IN8bio, Inc. | -30 Million USD | -686.273% |
| Kodiak Sciences Inc. | -260.49 Million USD | 9.426% |
| Annexon, Inc. | -134.23 Million USD | -75.762% |
| Adverum Biotechnologies, Inc. | -117.16 Million USD | -101.372% |
| Assembly Biosciences, Inc. | -61.22 Million USD | -285.342% |
| Avalo Therapeutics, Inc. | -31.54 Million USD | -647.962% |
| Ionis Pharmaceuticals, Inc. | -366.28 Million USD | 35.587% |
| Eyenovia, Inc. | -27.26 Million USD | -765.471% |
| Puma Biotechnology, Inc. | 21.59 Million USD | 1192.756% |
| Conduit Pharmaceuticals Inc. | -535 Thousand USD | -44000.374% |
| Xilio Therapeutics, Inc. | -76.4 Million USD | -208.802% |
| Arcellx, Inc. | -70.69 Million USD | -233.763% |
| Cardiff Oncology, Inc. | -41.44 Million USD | -469.332% |
| Enanta Pharmaceuticals, Inc. | -133.81 Million USD | -76.314% |
| Regulus Therapeutics Inc. | -30.03 Million USD | -685.488% |
| Moolec Science SA | -51.78 Million USD | -355.575% |
| Acumen Pharmaceuticals, Inc. | -52.37 Million USD | -350.511% |
| Geron Corporation | -184.12 Million USD | -28.138% |
| LAVA Therapeutics N.V. | -41.97 Million USD | -462.103% |
| Royalty Pharma plc | 1.13 Billion USD | 120.79% |
| Atea Pharmaceuticals, Inc. | -135.95 Million USD | -73.539% |
| Greenwich LifeSciences, Inc. | -8.89 Million USD | -2553.421% |
| TFF Pharmaceuticals, Inc. | -21.24 Million USD | -1010.646% |
| Mersana Therapeutics, Inc. | -171.67 Million USD | -37.436% |
| Humacyte, Inc. | -110.77 Million USD | -112.986% |
| Structure Therapeutics Inc. | -89.62 Million USD | -163.264% |
| 89bio, Inc. | -142.18 Million USD | -65.932% |
| PMV Pharmaceuticals, Inc. | -68.96 Million USD | -242.136% |
| Avenue Therapeutics, Inc. | -10.37 Million USD | -2173.653% |
| Genelux Corporation | -28.29 Million USD | -733.788% |
| Trevi Therapeutics, Inc. | -29.06 Million USD | -711.756% |
| Lexicon Pharmaceuticals, Inc. | -177.11 Million USD | -33.208% |
| Notable Labs, Ltd. | -11.26 Million USD | -1994.611% |
| Liquidia Corporation | -78.5 Million USD | -200.549% |
| Mustang Bio, Inc. | -51.6 Million USD | -357.225% |
| Immunovant, Inc. | -259.33 Million USD | 9.023% |
| Quantum-Si incorporated | -95.96 Million USD | -145.87% |
| Arbutus Biopharma Corporation | -72.84 Million USD | -223.871% |
| DiaMedica Therapeutics Inc. | -19.38 Million USD | -1117.362% |
| Vera Therapeutics, Inc. | -95.99 Million USD | -145.793% |
| Acasti Pharma Inc. | -12.85 Million USD | -1735.657% |
| MiNK Therapeutics, Inc. | -22.45 Million USD | -950.577% |
| Pasithea Therapeutics Corp. | -15.96 Million USD | -1378.148% |
| Xenon Pharmaceuticals Inc. | -182.39 Million USD | -29.356% |
| Elevai Labs, Inc. Common Stock | -4.3 Million USD | -5384.972% |
| NeuroBo Pharmaceuticals, Inc. | -12.47 Million USD | -1792.037% |
| Tempest Therapeutics, Inc. | -29.49 Million USD | -700.031% |
| Soleno Therapeutics, Inc. | -38.98 Million USD | -505.153% |
| PepGen Inc. | -78.62 Million USD | -200.075% |
| Moleculin Biotech, Inc. | -29.76 Million USD | -692.559% |
| United Therapeutics Corporation | 984.8 Million USD | 123.958% |
| Nuvectis Pharma, Inc. | -22.26 Million USD | -959.915% |
| Solid Biosciences Inc. | -96.01 Million USD | -145.729% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -4824.109% |
| Immuneering Corporation | -53.47 Million USD | -341.238% |
| Lixte Biotechnology Holdings, Inc. | -5.08 Million USD | -4538.012% |
| Silo Pharma, Inc. | -3.7 Million USD | -6275.499% |
| Belite Bio, Inc | -31.63 Million USD | -645.881% |
| XOMA Corporation | -40.83 Million USD | -477.838% |
| ARS Pharmaceuticals, Inc. | -54.36 Million USD | -333.987% |
| Bionomics Limited | -15.49 Billion USD | 98.477% |
| Apogee Therapeutics, Inc. | -83.98 Million USD | -180.928% |
| Alpha Tau Medical Ltd. | -29.15 Million USD | -709.195% |
| uniQure N.V. | -308.47 Million USD | 23.516% |
| Cassava Sciences, Inc. | -97.21 Million USD | -142.691% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -3126.832% |
| Poseida Therapeutics, Inc. | -123.43 Million USD | -91.15% |
| Forte Biosciences, Inc. | -31.47 Million USD | -649.577% |
| Anebulo Pharmaceuticals, Inc. | -8.2 Million USD | -2776.683% |
| Enlivex Therapeutics Ltd. | -29.06 Million USD | -711.673% |
| Conduit Pharmaceuticals Inc. | -535 Thousand USD | -44000.374% |
| SeaStar Medical Holding Corporation | -26.23 Million USD | -799.424% |
| FibroBiologics, Inc. Common Stock | -16.48 Million USD | -1331.222% |
| Altimmune, Inc. | -88.44 Million USD | -166.755% |
| Amicus Therapeutics, Inc. | -151.58 Million USD | -55.648% |
| Alpha Tau Medical Ltd. | -29.15 Million USD | -709.195% |
| Compugen Ltd. | -18.75 Million USD | -1158.062% |
| Peak Bio, Inc. | -1259.26 USD | -18736062.508% |
| Zevra Therapeutics, Inc. | -46.04 Million USD | -412.361% |
| Benitec Biopharma Inc. | -21.75 Million USD | -984.718% |
| Spyre Therapeutics, Inc. | -338.79 Million USD | 30.359% |
| NKGen Biotech, Inc. Common Stock | -82.95 Million USD | -184.419% |
| Zura Bio Limited | -60.36 Million USD | -290.883% |
| PolyPid Ltd. | -23.86 Million USD | -888.632% |
| Aileron Therapeutics, Inc. | -15.73 Million USD | -1399.727% |
| NKGen Biotech, Inc. Warrants | -82.95 Million USD | -184.419% |
| Instil Bio, Inc. | -156.08 Million USD | -51.157% |
| argenx SE | -295.05 Million USD | 20.036% |
| Immunome, Inc. | -106.8 Million USD | -120.902% |
| Compass Therapeutics, Inc. | -42.49 Million USD | -455.224% |
| Verona Pharma plc | -54.36 Million USD | -333.955% |
| enGene Holdings Inc. Warrants | -99.91 Million USD | -136.133% |
| Shattuck Labs, Inc. | -87.29 Million USD | -170.266% |
| CervoMed Inc. | -2.17 Million USD | -10763.296% |
| LENZ Therapeutics, Inc. | -124.65 Million USD | -89.278% |
| Plus Therapeutics, Inc. | -13.31 Million USD | -1671.831% |
| Dianthus Therapeutics, Inc. | -43.55 Million USD | -441.699% |
| Moolec Science SA | -51.78 Million USD | -355.575% |
| Enveric Biosciences, Inc. | -17.29 Thousand USD | -1364349.942% |
| Inovio Pharmaceuticals, Inc. | -135.11 Million USD | -74.616% |
| AnaptysBio, Inc. | -163.61 Million USD | -44.199% |
| Design Therapeutics, Inc. | -66.86 Million USD | -252.872% |
| Leap Therapeutics, Inc. | -81.41 Million USD | -189.799% |
| NeurAxis, Inc. | -14.62 Million USD | -1513.059% |
| Seelos Therapeutics, Inc. | -37.88 Million USD | -522.821% |
| Lumos Pharma, Inc. | -34.03 Million USD | -593.239% |
| Achilles Therapeutics plc | -69.66 Million USD | -238.674% |
| enGene Holdings Inc. Common Stock | -99.91 Million USD | -136.133% |
| 180 Life Sciences Corp. | -19.93 Million USD | -1083.525% |
| Opiant Pharmaceuticals, Inc. | 3 Million USD | 7941.591% |
| CERo Therapeutics Holdings, Inc. | -2536.23 USD | -9302565.768% |
| Nutriband Inc. | -5.48 Million USD | -4201.249% |
| ORIC Pharmaceuticals, Inc. | -100.69 Million USD | -134.304% |
| CG Oncology, Inc. Common stock | -48.6 Million USD | -385.397% |
| Fractyl Health, Inc. Common Stock | -77.09 Million USD | -206.05% |
| Rani Therapeutics Holdings, Inc. | -33.97 Million USD | -594.545% |
| MoonLake Immunotherapeutics | -36 Million USD | -555.248% |
| Palisade Bio, Inc. | -12.3 Million USD | -1818.187% |
| Tourmaline Bio, Inc. | -42.12 Million USD | -460.101% |
| Beam Therapeutics Inc. | -132.52 Million USD | -78.029% |
| Neurogene Inc. | -36.31 Million USD | -549.66% |
| Mirum Pharmaceuticals, Inc. | -163.41 Million USD | -44.379% |
| AEON Biopharma, Inc. | -52.55 Million USD | -348.925% |
| CARGO Therapeutics, Inc. Common Stock | -98.14 Million USD | -140.391% |
| Sesen Bio, Inc. | -19.88 Million USD | -1086.567% |
| Enliven Therapeutics, Inc. | -71.58 Million USD | -229.595% |
| Kiora Pharmaceuticals, Inc. | -12.51 Million USD | -1785.4% |
| Iovance Biotherapeutics, Inc. | -444.03 Million USD | 46.865% |
| Taysha Gene Therapies, Inc. | -111.56 Million USD | -111.478% |
| Athira Pharma, Inc. | -117.67 Million USD | -100.504% |
| Vaccinex, Inc. | -20.25 Million USD | -1065.063% |
| HCW Biologics Inc. | -24.99 Million USD | -843.964% |
| XOMA Corporation | -40.83 Million USD | -477.838% |
| Nektar Therapeutics | -276.05 Million USD | 14.533% |
| Arvinas, Inc. | -367.3 Million USD | 35.764% |
| Tevogen Bio Holdings Inc. | -67.32 Thousand USD | -350344.857% |
| Merus N.V. | -154.93 Million USD | -52.277% |
| Omega Therapeutics, Inc. | -97.42 Million USD | -142.165% |
| Quince Therapeutics, Inc. | -31.38 Million USD | -651.751% |
| Rezolute, Inc. | -68.45 Million USD | -244.64% |
| Clene Inc. | -49.5 Million USD | -376.602% |
| Indaptus Therapeutics, Inc. | -15.42 Million USD | -1429.727% |
| BeyondSpring Inc. | -21.02 Million USD | -1022.12% |
| Synlogic, Inc. | -57.28 Million USD | -311.887% |
| Allarity Therapeutics, Inc. | -11.9 Million USD | -1882.497% |
| Phio Pharmaceuticals Corp. | -10.82 Million USD | -2079.355% |
| Peak Bio, Inc. | -1259.26 USD | -18736062.508% |
| Werewolf Therapeutics, Inc. | -37.36 Million USD | -531.388% |
| Krystal Biotech, Inc. | 10.93 Million USD | 2258.224% |
| Karyopharm Therapeutics Inc. | -143.09 Million USD | -64.877% |
| SpringWorks Therapeutics, Inc. | -325.1 Million USD | 27.427% |
| Lipella Pharmaceuticals Inc. | -4.61 Million USD | -5008.006% |
| MannKind Corporation | -11.93 Million USD | -1876.353% |
| Ikena Oncology, Inc. | -68.16 Million USD | -246.121% |
| Cyclerion Therapeutics, Inc. | -21.01 Million USD | -1022.708% |
| Gyre Therapeutics, Inc. | -92.93 Million USD | -153.879% |
| Gossamer Bio, Inc. | -179.81 Million USD | -31.21% |
| CohBar, Inc. | -11.96 Million USD | -1872.368% |
| Cognition Therapeutics, Inc. | -25.78 Million USD | -814.91% |
| NRx Pharmaceuticals, Inc. | -30.15 Million USD | -682.544% |
| Legend Biotech Corporation | -518.25 Million USD | 54.475% |
| Mural Oncology plc | -207.44 Million USD | -13.734% |
| Biora Therapeutics, Inc. | -124.11 Million USD | -90.095% |
| PaxMedica, Inc. Common Stock | -18.28 Million USD | -1189.998% |
| Disc Medicine, Inc. | -76.42 Million USD | -208.701% |
| Champions Oncology, Inc. | -7.27 Million USD | -3142.675% |
| REGENXBIO Inc. | -263.49 Million USD | 10.458% |
| Ensysce Biosciences, Inc. | -10.61 Million USD | -2123.079% |
| Anavex Life Sciences Corp. | -47.5 Million USD | -396.657% |
| Cellectar Biosciences, Inc. | -37.98 Million USD | -521.157% |
| Edgewise Therapeutics, Inc. | -100.16 Million USD | -135.553% |
| Vaxart, Inc. | -82.46 Million USD | -186.106% |
| PharmaCyte Biotech, Inc. | 333.76 Thousand USD | 70789.981% |
| Aldeyra Therapeutics, Inc. | -37.54 Million USD | -528.453% |
| Cellectis S.A. | -101.05 Million USD | -133.465% |
| Longeveron Inc. | -21.41 Million USD | -1001.84% |
| Repare Therapeutics Inc. | -93.79 Million USD | -151.543% |
| Sarepta Therapeutics, Inc. | -535.97 Million USD | 55.98% |
| Inozyme Pharma, Inc. | -71.16 Million USD | -231.517% |
| Revolution Medicines, Inc. | -436.36 Million USD | 45.932% |
| Nymox Pharmaceutical Corporation | -6.57 Million USD | -3490.58% |
| Third Harmonic Bio, Inc. | -30.82 Million USD | -665.433% |
| ArriVent BioPharma, Inc. Common Stock | -69.33 Million USD | -240.295% |
| AN2 Therapeutics, Inc. | -64.73 Million USD | -264.483% |
| Anixa Biosciences, Inc. | -9.81 Million USD | -2304.821% |
| Vertex Pharmaceuticals Incorporated | 3.61 Billion USD | 106.518% |
| Denali Therapeutics Inc. | -145.22 Million USD | -62.464% |
| Revelation Biosciences, Inc. | -120.25 Thousand USD | -196098.879% |
| Veru Inc. | -93.15 Million USD | -153.28% |
| Corvus Pharmaceuticals, Inc. | -27.02 Million USD | -772.903% |
| Cingulate Inc. | -23.53 Million USD | -902.496% |
| Passage Bio, Inc. | -102.06 Million USD | -131.17% |
| Context Therapeutics Inc. | -23.96 Million USD | -884.539% |
| Exicure, Inc. | -16.91 Million USD | -1294.921% |
| Day One Biopharmaceuticals, Inc. | -188.91 Million USD | -24.889% |
| Oramed Pharmaceuticals Inc. | -37.76 Million USD | -524.767% |
| Scinai Immunotherapeutics Ltd. | -6.5 Million USD | -3525.714% |
| Rhythm Pharmaceuticals, Inc. | -184.67 Million USD | -27.756% |
| Nuvalent, Inc. | -126.21 Million USD | -86.927% |
| ABVC BioPharma, Inc. | -10.51 Million USD | -2143.674% |
| Carisma Therapeutics, Inc. | -86.87 Million USD | -171.57% |
| Unicycive Therapeutics, Inc. | -30.54 Million USD | -672.45% |
| OmniAb, Inc. | -50.61 Million USD | -366.104% |
| Anew Medical, Inc. | 1.34 Million USD | 17627.124% |
| Fennec Pharmaceuticals Inc. | -16.04 Million USD | -1370.471% |
| Lipocine Inc. | -16.35 Million USD | -1342.856% |
| Lexeo Therapeutics, Inc. Common Stock | -66.39 Million USD | -255.359% |
| Nautilus Biotechnology, Inc. | -63.67 Million USD | -270.533% |
| SAB Biotherapeutics, Inc. | -42.19 Million USD | -459.175% |
| G1 Therapeutics, Inc. | -47.96 Million USD | -391.874% |
| Bellerophon Therapeutics, Inc. | -19.83 Million USD | -1089.738% |
| Sage Therapeutics, Inc. | -541.48 Million USD | 56.428% |
| Ocugen, Inc. | -63.07 Million USD | -274.04% |
| Mind Medicine (MindMed) Inc. | -95.73 Million USD | -146.456% |
| Q32 Bio Inc. | -112.96 Million USD | -108.866% |
| Brainstorm Cell Therapeutics Inc. | -17.19 Million USD | -1272.365% |
| Alumis Inc. Common Stock | -154.99 Million USD | -52.224% |
| Equillium, Inc. | -13.33 Million USD | -1669.306% |
| Kyverna Therapeutics, Inc. | -60.36 Million USD | -290.844% |
| Coya Therapeutics, Inc. | -7.98 Million USD | -2853.704% |
| CNS Pharmaceuticals, Inc. | -18.85 Million USD | -1151.574% |
| Galera Therapeutics, Inc. | -59.08 Million USD | -299.338% |
| Evelo Biosciences, Inc. | -114.52 Million USD | -106.01% |
| Comera Life Sciences Holdings, Inc. | -18.37 Million USD | -1183.804% |
| Dominari Holdings Inc. | -22.88 Million USD | -931.103% |
| Edesa Biotech, Inc. | -8.37 Million USD | -2717.355% |
| vTv Therapeutics Inc. | -20.25 Million USD | -1065.121% |
| Bio-Techne Corporation | 168.1 Million USD | 240.351% |
| Agios Pharmaceuticals, Inc. | -352.08 Million USD | 32.989% |
| Harmony Biosciences Holdings, Inc. | 128.85 Million USD | 283.106% |
| Prelude Therapeutics Incorporated | -121.83 Million USD | -93.658% |
| Candel Therapeutics, Inc. | -37.93 Million USD | -521.885% |
| iTeos Therapeutics, Inc. | -112.64 Million USD | -109.457% |
| Nkarta, Inc. | -117.5 Million USD | -100.796% |
| BioCardia, Inc. | -11.57 Million USD | -1939.037% |
| Iterum Therapeutics plc | -38.37 Million USD | -514.884% |